Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Purcell to run Perseus-Soros venture

Dennis Purcell was to announce today that he is leaving his banking post at Chase H&Q to join Perseus-Soros Biopharmaceutical Fund, a new

Read the full 232 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE